| Schedule of segment information |
Schedule of segment information
| |
|
Cannabis and Medical Marijuana Segment
|
|
|
Facilities Operations Related
|
|
|
Corporate, Other, and Eliminations
|
|
|
Consolidated |
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net sales |
|
$ |
40,764 |
|
|
$ |
5,969,674 |
|
|
$ |
- |
|
|
$ |
6,010,438 |
|
| Operating income (loss) |
|
|
26,849 |
|
|
|
95,336 |
|
|
|
(526,521 |
) |
|
|
(404,336 |
) |
| Interest income |
|
|
- |
|
|
|
3 |
|
|
|
70,226 |
|
|
|
70,229 |
|
| Interest expense |
|
|
- |
|
|
|
38,330 |
|
|
|
24,062 |
|
|
|
62,392 |
|
| Total assets |
|
|
900,484 |
|
|
|
2,240,047 |
|
|
|
1,645,910 |
|
|
|
4,786,441 |
|
| Property additions |
|
|
- |
|
|
|
160,102 |
|
|
|
1,264 |
|
|
|
161,366 |
|
| Fixed asset depreciation and amortization |
|
|
- |
|
|
|
45,936 |
|
|
|
5,744 |
|
|
|
51,710 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net sales |
|
$ |
47,707 |
|
|
$ |
4,778,249 |
|
|
$ |
- |
|
|
$ |
4,825,956 |
|
| Operating income (loss) |
|
|
(13,258 |
) |
|
|
(231,162 |
) |
|
|
(829,684 |
) |
|
|
(1,074,104 |
) |
| Interest income |
|
|
- |
|
|
|
- |
|
|
|
92,571 |
|
|
|
92,571 |
|
| Interest expense |
|
|
- |
|
|
|
34,711 |
|
|
|
584 |
|
|
|
35,295 |
|
| Total assets |
|
|
1,042,553 |
|
|
|
1,874,519 |
|
|
|
1,524,023 |
|
|
|
4,441,095 |
|
| Property additions |
|
|
- |
|
|
|
126,396 |
|
|
|
7,593 |
|
|
|
133,989 |
|
| Fixed asset depreciation and amortization |
|
|
- |
|
|
|
20,553 |
|
|
|
7,103 |
|
|
|
27,656 |
|
|
| Reconciliation of revenue from segments to consolidated |
The
following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income
taxes for the years ended December 31, 2021 and 2020, as presented in the consolidated income statements:
Reconciliation of revenue from segments to consolidated
| |
|
2021 |
|
|
2020 |
|
| Operating loss |
|
$ |
(404,336 |
) |
|
$ |
(1,074,104 |
) |
| Realized gain (loss) on investments in securities |
|
|
1,017 |
|
|
|
(14,961 |
) |
| Gain on sale of GlauCanna rights |
|
|
- |
|
|
|
31,000 |
|
| Impairment of investments |
|
|
22,718 |
|
|
|
(139,148 |
) |
| Interest income |
|
|
70,229 |
|
|
|
92,571 |
|
| Interest expense |
|
|
(62,392 |
) |
|
|
(35,295 |
) |
| Gain (loss) on equipment disposals |
|
|
86 |
|
|
|
67 |
|
| PPP loan forgiven |
|
|
87,122 |
|
|
|
452,348 |
|
| EIDL Grant |
|
|
- |
|
|
|
10,000 |
|
| Other income |
|
|
38,870 |
|
|
|
10,031 |
|
|